Pharmacological properties:
Affects the exchange processes in the hyaline cartilage, reduces the degenerative changes in the cartilage tissue of the joints, stimulates the biosynthesis of glucosaminoglycans. In the treatment ARTRAVIR®-INCAMPHAR®® reduces soreness and improves mobility of affected joints.
Pharmacodynamics:
Chondroitin sulfate is a natural component of cartilaginous tissue.
Degenerative changes in the joints are accompanied by its loss. The drug ARTRAVIR ® - INKAMFARM ® serves as a substitute therapy.In the treatment of degenerative joint changes accompanied by a secondary synovitis, a positive effect is observed after 2-3 weeks after the start of the drug application. The pain in the joints decreases, the clinical manifestations of the reactive synovitis disappear, the volume of movements in the affected joints increases.
The therapeutic effect persists for a long time after the end of the course of treatment.